BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5791773)

  • 1. Arabinosyl-6-mercaptopurine and arabinosyl-6-mercaptopurine-5'-phosphate: comparison of their metabolic effects.
    LePage GA; Bell JP; Wilson MJ
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):1038-41. PubMed ID: 5791773
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic nucleotide analogs as carcinostatic agents.
    LePage GA; Hersh EM
    Biochem Biophys Res Commun; 1972 Mar; 46(5):1918-22. PubMed ID: 5015235
    [No Abstract]   [Full Text] [Related]  

  • 3. Arabinosyladenine and arabinosylhypoxanthine metabolism in murine tumor cells.
    LePage GA
    Can J Biochem; 1970 Jan; 48(1):75-8. PubMed ID: 5512545
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.
    Bennett LL; Allan PW
    Cancer Res; 1971 Feb; 31(2):152-8. PubMed ID: 5545266
    [No Abstract]   [Full Text] [Related]  

  • 5. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS; MUSSER EA; BOSTWICK L; MENGEL GD
    Cancer Res; 1964 Aug; 24():1285-93. PubMed ID: 14216163
    [No Abstract]   [Full Text] [Related]  

  • 6. THE METABOLISM OF 9-ARABINOSYL-6-MERCAPTOPURINE IN NORMAL AND NEOPLASTIC TISSUES.
    KIMBALL AP; LEPAGE GA; BOWMAN B
    Can J Biochem; 1964 Dec; 42():1753-68. PubMed ID: 14241609
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of the anticancer activity of some S-substituted derivatives of 6-mercaptopurine and their ribonucleosides.
    MONTGOMERY JA; JOHNSTON TP; GALLAGHER A; STRINGFELLOW CR; SCHABEL FM
    J Med Pharm Chem; 1961 Mar; 3():265-88. PubMed ID: 14475542
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental evaluation of potential anticancer agents. IX. The ribonucleosides and ribonucleotides of two purine antagonists.
    MONTGOMERY JA; SCHABEL FM; SKIPPER HE
    Cancer Res; 1962 May; 22():504-9. PubMed ID: 14475543
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of purine nucleotide biosynthesis by 3-deazaguanine, its nucleoside and 5'-nucleotide.
    Streeter DG; Koyama HH
    Biochem Pharmacol; 1976 Nov; 25(21):2413-5. PubMed ID: 1033766
    [No Abstract]   [Full Text] [Related]  

  • 10. The determination of the uptake of arabinosyl-6-mercaptopurine by L1210 cells.
    Chao DL; Kimball AP
    Biochim Biophys Acta; 1972 Jun; 266(3):721-5. PubMed ID: 5040251
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and biological activity of certain 8-mercaptopurine and 6-mercaptopyrimidine S-nucleosides.
    Shuman DA; Bloch A; Robins RK; Robins MJ
    J Med Chem; 1969 Jul; 12(4):653-7. PubMed ID: 4893463
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of periodate-oxidation products of carbohydrates and their derivatives.
    Dvonch W; Fletcher H; Gregory FJ; Healy EM; Warren GH; Alburn HE
    Cancer Res; 1966 Nov; 26(11):2386-9. PubMed ID: 4289174
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA).
    Prince HN; Grunberg E; Buck M; Cleeland R
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1080-6. PubMed ID: 4305347
    [No Abstract]   [Full Text] [Related]  

  • 14. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymidylate kinase as target enzyme for 5'-deoxythymidine and various 5'-deoxy-5'-halogeno pyrimidine nucleosides.
    Langen P; Kowollik G; Schütt M; Etzold G
    Acta Biol Med Ger; 1969; 23(6):Suppl:K 19+. PubMed ID: 5375492
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Ehrlich mouse ascites tumor growth by cordycepin.
    JAGGER DV; KREDICH NM; GUARINO AJ
    Cancer Res; 1961 Feb; 21():216-20. PubMed ID: 13789180
    [No Abstract]   [Full Text] [Related]  

  • 17. Concerning the site of action of deoxyadenosine (deoxyadenosinetriphosphate) upon the synthesis of nucleic acids in the cancer cell.
    Vornovitskaja GI; Shapot VS; Nicolskaja TI
    Biochim Biophys Acta; 1968 Sep; 166(2):596-9. PubMed ID: 4300636
    [No Abstract]   [Full Text] [Related]  

  • 18. ACTIVITY OF SELECTED COMPOUNDS IN SUBLINE OF LEUKEMIA L1210 RESISTANT TO CYTOSINE ARABINOSIDE (NSC-63878).
    WODINSKY I; KENSLER CJ
    Cancer Chemother Rep; 1964 Dec; 43():1-3. PubMed ID: 14250647
    [No Abstract]   [Full Text] [Related]  

  • 19. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
    BOOTH BA; SARTORELLI AC
    Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.